Jane Street Group, LLC Chemo Centryx, Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2022 May 17, 2022	SELL	$22.22 - $39.12 $6.7 Million - $11.8 Million	-301,700 Reduced 63.82%	171,000 $4.29 Million
Q4 2021 Feb 15, 2022	SELL	$18.38 - $40.5 $7.54 Million - $16.6 Million	-410,200 Reduced 46.46%	472,700 $17.2 Million
Q3 2021 Nov 16, 2021	BUY	$13.18 - $19.83 $7.92 Million - $11.9 Million	601,000 Added 213.2%	882,900 $15.1 Million
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $2.4 Million - $12.7 Million	250,300 Added 792.09%	281,900 $3.78 Million
Q1 2021 May 18, 2021	BUY	$49.53 - $68.4 $505,206 - $697,680	10,200 Added 47.66%	31,600 $1.62 Million
Q4 2020 Feb 17, 2021	SELL	$47.25 - $65.16 $5.11 Million - $7.04 Million	-108,100 Reduced 83.47%	21,400 $1.33 Million
Q3 2020 Nov 17, 2020	BUY	$46.35 - $61.69 $5.09 Million - $6.77 Million	109,800 Added 557.36%	129,500 $7.1 Million
Q2 2020 Aug 17, 2020	BUY	$38.58 - $65.07 $347,220 - $585,629	9,000 Added 84.11%	19,700 $1.13 Million
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $13,091 - $20,312	400 Added 3.88%	10,700 $430,000
Q4 2019 Feb 14, 2020	BUY	$6.81 - $39.55 $70,143 - $407,364	10,300 New	10,300 $407,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.